Delivery Order SPE2DB22D2206-SPE2DB25FKB29
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,805.40 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,321.72 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of OxyContin ER 30 mg tablets (100-count packages). This is a firm fixed price, non-set-aside contract with a completion date of August 27, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,256.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on May 23, 2025, with a completion date of May 27, 2025. This non-set-aside competitive award was placed for performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,112.81 for OxyContin ER 20 mg tablets (100-count supply) on September 15, 2025, with completion targeted for September 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX)...
- The Defense Logistics Agency awarded a delivery order valued at $1,003.64 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,292.15 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's Conshohocken, Pennsylvania facility, which serves as the prime...
- The Defense Logistics Agency awarded a $3,404.26 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. As a child contract action, this delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,916.57 on September 25, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contractor's place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,451.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $2,032.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) on July 24, 2025, with completion scheduled for July 25, 2025. This competitive award employs a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKB29Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,577.23 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 40 mg tablets (100 count) on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price, non-set-aside delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's DLA Troop Support Medical contract functions as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support Department of Defense healthcare programs. This delivery order for controlled pain management pharmaceutical reflects the company's role in fulfilling federal medical supply requirements through competitive, open contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/23/25 |